Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) EPS (Weighted Average and Diluted) (2023 - 2025)

Metagenomi (MGX) has disclosed EPS (Weighted Average and Diluted) for 3 consecutive years, with -$0.6 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 4.76% to -$0.6 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.37 through Dec 2025, up 9.54% year-over-year, with the annual reading at -$2.36 for FY2025, 0.0% changed from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.6 at Metagenomi, down from -$0.55 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.29 in Q2 2024, with the low at -$5.82 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$2.09, with a median of -$0.66 recorded in 2025.
  • The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 92.41% in 2024, then plummeted 86.21% in 2025.
  • Over 3 years, EPS (Weighted Average and Diluted) stood at -$5.67 in 2023, then skyrocketed by 88.89% to -$0.63 in 2024, then grew by 4.76% to -$0.6 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.6, -$0.55, and -$0.54 for Q4 2025, Q3 2025, and Q2 2025 respectively.